Prognostic Impact of Immunoglobulin Kappa C (<i>IGKC</i>) in Early Breast Cancer
We studied the prognostic impact of tumor immunoglobulin kappa C (<i>IGKC</i>) mRNA expression as a marker of the humoral immune system in the FinHer trial patient population, where 1010 patients with early breast cancer were randomly allocated to either docetaxel-containing or vinorelbi...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3626 |